AVE Science & Technology Co Ltd
AVE Science&Technology CO.,LTD researches, develops, manufactures, markets, and services medical devices, biological reagents, remote medical diagnosis network, computer software, automatic control devices, and medical auxiliary equipment China, Europe, the United States, Asia, Africa, and internationally. The company offers urine formed elements analyzer and related reagents, automatic urine ana… Read more
AVE Science & Technology Co Ltd (688067) - Total Liabilities
Latest total liabilities as of September 2025: CN¥93.09 Million CNY
Based on the latest financial reports, AVE Science & Technology Co Ltd (688067) has total liabilities worth CN¥93.09 Million CNY as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
AVE Science & Technology Co Ltd - Total Liabilities Trend (2012–2024)
This chart illustrates how AVE Science & Technology Co Ltd's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
AVE Science & Technology Co Ltd Competitors by Total Liabilities
The table below lists competitors of AVE Science & Technology Co Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Jacobio Pharmaceuticals Group Co. Ltd.
PINK:JBPHF
|
USA | $423.87 Million |
|
Silicius Real Estate SOCIMI S.A.
MC:YSIL
|
Spain | €275.11 Million |
|
Raymond Limited
NSE:RAYMOND
|
India | ₹16.01 Billion |
|
Francaise de l'Energie
LSE:0RIL
|
UK | €51.73 Million |
|
Yunnan Yuntou Ecology and Environment Technology Co Ltd
SHE:002200
|
China | CN¥2.94 Billion |
|
CNNC International Limited
F:U7MA
|
Germany | €840.53 Million |
|
Lucid Diagnostics Inc
NASDAQ:LUCD
|
USA | $27.36 Million |
|
The Nisshin OilliO GroupLtd.
OTCGREY:NSOMF
|
USA | $217.54 Billion |
Liability Composition Analysis (2012–2024)
This chart breaks down AVE Science & Technology Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 5.05 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.18 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.15 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how AVE Science & Technology Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for AVE Science & Technology Co Ltd (2012–2024)
The table below shows the annual total liabilities of AVE Science & Technology Co Ltd from 2012 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | CN¥65.15 Million | -2.53% |
| 2023-12-31 | CN¥66.85 Million | -10.31% |
| 2022-12-31 | CN¥74.53 Million | +6.43% |
| 2021-12-31 | CN¥70.03 Million | +17.01% |
| 2020-12-31 | CN¥59.85 Million | +33.19% |
| 2019-12-31 | CN¥44.94 Million | +11.24% |
| 2018-12-31 | CN¥40.40 Million | +18.35% |
| 2017-12-31 | CN¥34.13 Million | +1.78% |
| 2016-12-31 | CN¥33.54 Million | +76.59% |
| 2015-12-31 | CN¥18.99 Million | -16.14% |
| 2014-12-31 | CN¥22.65 Million | +13.20% |
| 2013-12-31 | CN¥20.01 Million | +6.85% |
| 2012-12-31 | CN¥18.72 Million | -- |